New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin
Authors:
- Daniel Y. BargieriDBDaniel Y. Bargieri
- Daniela S. RosaDRDaniela S. Rosa
- Fabio T.M. CostaFabio T.M. Costa
- Irene S. SoaresISIrene S. Soares
- Luis C.S. FerreiraLFLuis C.S. Ferreira
- Mauricio M. RodriguesMRMauricio M. Rodrigues
- 1 November 2008
- Vol. 26 (48) , 6132-6142
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding ProteinPLOS Medicine, 2007
- Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titerMalaria Journal, 2007
- Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum MalariaPLoS Clinical Trials, 2007
- Immunity to RecombinantPlasmodium falciparumMerozoite Surface Protein 1 (MSP1): Protection inAotus nancymaiMonkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory ActivityInfection and Immunity, 2006
- Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infectionJournal of Experimental Medicine, 2006
- Flagellin-Deficient Legionella Mutants Evade Caspase-1- and Naip5-Mediated Macrophage ImmunityPLOS Pathogens, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motilityNature Immunology, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.Journal of Experimental Medicine, 1990